Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 12

    1.

    Atypical presentation of multiple evanescent white dot syndrome involving granular lesions of varying size.

    Khurana RN, Albini T, Dea MK, Rao NA, Lim JI.

    Am J Ophthalmol. 2005 May;139(5):935-7.PMID: 15860314 [PubMed - indexed for MEDLINE]Related articles

    2.

    Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.

    Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN.

    Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E454-61. Epub 2004 Nov 2.PMID: 15522994 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Mechanism of action in dogs of slow-acting insulin analog O346.

    Ellmerer M, Hamilton-Wessler M, Kim SP, Dea MK, Kirkman E, Perianayagam A, Markussen J, Bergman RN.

    J Clin Endocrinol Metab. 2003 May;88(5):2256-62.PMID: 12727983 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.

    van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN.

    J Clin Endocrinol Metab. 2002 Nov;87(11):5191-8.PMID: 12414891 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake.

    Dea MK, Hamilton-Wessler M, Ader M, Moore D, Schäffer L, Loftager M, Vølund A, Bergman RN.

    Diabetes. 2002 Mar;51(3):762-9.PMID: 11872677 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion.

    Hamilton-Wessler M, Ader M, Dea MK, Moore D, Loftager M, Markussen J, Bergman RN.

    Diabetes. 2002 Mar;51(3):574-82.PMID: 11872653 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model.

    Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, Bergman RN.

    Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E375-83.PMID: 11440915 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Central role of the adipocyte in the metabolic syndrome.

    Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M.

    J Investig Med. 2001 Jan;49(1):119-26. Review.PMID: 11217141 [PubMed - indexed for MEDLINE]Related articles

    9.

    Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.

    Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN.

    Diabetes. 2000 Dec;49(12):2116-25.PMID: 11118015 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.

    Dea MK, Van Citters GW, Ader M, Mittelman SD, Sunehag AL, Bergman RN.

    Diabetes. 2000 Dec;49(12):2087-93.PMID: 11118011 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.

    Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN.

    J Clin Invest. 2000 Aug;106(3):421-30.PMID: 10930445 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile.

    Getty L, Hamilton-Wessler M, Ader M, Dea MK, Bergman RN.

    Diabetes. 1998 Dec;47(12):1941-7.PMID: 9836528 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...